GFAP
-
Alzheimer’s disease, blood biomarkers, Brain, capillary blood sampling, cognition, cognitive impairment, dementia screening, fingerprick test, GFAP, Neurodegenerative Diseases, neuroscience, p-tau217, PROTECT study, remote testingAlzheimer’s Fingerprick Blood Biomarkers: p-tau217 and GFAP Track Cognition
A 2026 PROTECT study involving 174 older adults found that self-administered fingerprick…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
